000 01186nam a2200277 a 4500
005 20260817161355.0
008 251029s2025 sz a o 000 0 eng d
020 _a9789240116092
035 _a.b12466396
050 4 _aRC271 A35
_bA23 2025eb
245 0 0 _aAccelerating the development of priority formulations in childhood cancer
_h[electronic resource] :
_btarget product profiles for paediatric formulations of cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine, temozolomide
260 _aGeneva :
_bWorld Health Organization,
_c2025
300 _a1 online resource (63 pages) :
_bill.
650 0 _aDrug development
650 0 _aCancer in children
_xAdjuvant treatment
650 0 _aCancer in children
710 2 _aWorld Health Organization
856 _3Free eBook from WHO
_uhttps://www.who.int/publications/i/item/9789240116092
907 _a.b12466396
_bweb
_ct
902 _a251031
998 _b0
_c251029
_de
_eh
_ft
_g0
945 _lweb
942 _c15
909 _aBarcode : -
_bCREATED : 2025-10-29
_cRECORD # : i13560451
_dLPATRON : 0
_eLCHKIN : -
_f# RENEWALS : 0
_g# OVERDUE : 0
_hIUSE3 : 0
_iTOT CHKOUT : 0
_jTOT RENEW : 0
999 _c1055
_d1055